Merck is passionate about improving health. We are committed to accelerating every step in the journey in our quest to bring treatment options to people with cancer.
Clinical trials for prostate cancer are underway and currently enrolling patients. If you have patients with prostate cancer, you may want to consider a Merck Oncology Clinical Trial.
To see if your patients qualify for one of these trials, contact our clinical trial information center at 1-888-577-8839. If you are interested in partnering with us as an investigator, call 1-800-290-4339.
|Trial Description||Trial Number||Condition||Phase||Status|
||365||Metastatic Castration-Resistant Prostate Cancer||Phase 1||Recruiting|
||199||Metastatic Castration-resistant Prostate Cancer||Phase 2||Active, not recruiting|
||7339-010||Prostatic Neoplasms||Phase 3||Recruiting|
||641||Prostatic Neoplasms||Phase 3||Not yet recruiting|
||921||Prostatic Neoplasms||Phase 3||Recruiting|